These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36137904)

  • 21. Are pigs overestimated as a source of zoonotic influenza viruses?
    Hennig C; Graaf A; Petric PP; Graf L; Schwemmle M; Beer M; Harder T
    Porcine Health Manag; 2022 Jun; 8(1):30. PubMed ID: 35773676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The genomic landscape of swine influenza A viruses in Southeast Asia.
    Zeller MA; Ma J; Wong FY; Tum S; Hidano A; Holt H; Chhay T; Sorn S; Koeut D; Seng B; Chao S; Ng GGK; Yan Z; Chou M; Rudge JW; Smith GJD; Su YCF
    Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2301926120. PubMed ID: 37552753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines.
    Loeffen WL; Stockhofe N; Weesendorp E; van Zoelen-Bos D; Heutink R; Quak S; Goovaerts D; Heldens JG; Maas R; Moormann RJ; Koch G
    Vet Microbiol; 2011 Sep; 152(3-4):304-14. PubMed ID: 21664078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Orf-Virus (ORFV)-Based Vector Expressing a Consensus H1 Hemagglutinin Provides Protection against Diverse Swine Influenza Viruses.
    do Nascimento GM; Bugybayeva D; Patil V; Schrock J; Yadagiri G; Renukaradhya GJ; Diel DG
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Bivalent Live Attenuated Influenza Virus Vaccine Protects against Drifted H1N2 and H3N2 Clinical Isolates in Swine.
    Aubrey L; Barron-Castillo U; Detmer S; Zhou Y
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs.
    Renu S; Feliciano-Ruiz N; Patil V; Schrock J; Han Y; Ramesh A; Dhakal S; Hanson J; Krakowka S; Renukaradhya GJ
    Front Immunol; 2021; 12():584299. PubMed ID: 33746943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination of pigs with a codon-pair bias de-optimized live attenuated influenza vaccine protects from homologous challenge.
    Kaplan BS; Souza CK; Gauger PC; Stauft CB; Robert Coleman J; Mueller S; Vincent AL
    Vaccine; 2018 Feb; 36(8):1101-1107. PubMed ID: 29366707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A split influenza vaccine formulated with a combination adjuvant composed of alpha-D-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigs.
    Patil V; Hernandez-Franco JF; Yadagiri G; Bugybayeva D; Dolatyabi S; Feliciano-Ruiz N; Schrock J; Hanson J; Ngunjiri J; HogenEsch H; Renukaradhya GJ
    J Nanobiotechnology; 2022 Nov; 20(1):477. PubMed ID: 36369044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease.
    Wymore Brand M; Anderson TK; Kitikoon P; Brian Kimble J; Otis N; Gauger PC; Souza CK; Kaplan B; Mogler M; Strait E; Vincent Baker AL
    Vaccine; 2022 Sep; 40(38):5569-5578. PubMed ID: 35987871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of live attenuated influenza vaccine virus and evidence of reassortment in the U.S. swine population.
    Sharma A; Zeller MA; Li G; Harmon KM; Zhang J; Hoang H; Anderson TK; Vincent AL; Gauger PC
    J Vet Diagn Invest; 2020 Mar; 32(2):301-311. PubMed ID: 32100644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.
    Wen F; Yu H; Yang FR; Huang M; Yang S; Zhou YJ; Li ZJ; Tong GZ
    Arch Virol; 2014 Nov; 159(11):2957-67. PubMed ID: 24957653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JMM Profile: Swine influenza A virus: a neglected virus with pandemic potential.
    Mollett BC; Everett HE; van Diemen PM; Byrne AMP; Ramsay A; James J; Reid SM; Hansen RDE; Lewis NS; Brown IH; Banyard AC
    J Med Microbiol; 2023 Jan; 72(1):. PubMed ID: 36748620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United States.
    Rajão DS; Gauger PC; Anderson TK; Lewis NS; Abente EJ; Killian ML; Perez DR; Sutton TC; Zhang J; Vincent AL
    J Virol; 2015 Nov; 89(22):11213-22. PubMed ID: 26311895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance of European Domestic Pig Populations Identifies an Emerging Reservoir of Potentially Zoonotic Swine Influenza A Viruses.
    Henritzi D; Petric PP; Lewis NS; Graaf A; Pessia A; Starick E; Breithaupt A; Strebelow G; Luttermann C; Parker LMK; Schröder C; Hammerschmidt B; Herrler G; Beilage EG; Stadlbauer D; Simon V; Krammer F; Wacheck S; Pesch S; Schwemmle M; Beer M; Harder TC
    Cell Host Microbe; 2020 Oct; 28(4):614-627.e6. PubMed ID: 32721380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice.
    Ruan BY; Yao Y; Wang SY; Gong XQ; Liu XM; Wang Q; Yu LX; Zhu SQ; Wang J; Shan TL; Zhou YJ; Tong W; Zheng H; Li GX; Gao F; Kong N; Yu H; Tong GZ
    Vet Microbiol; 2020 Jul; 246():108724. PubMed ID: 32605742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression.
    Dlugolenski D; Jones L; Howerth E; Wentworth D; Tompkins SM; Tripp RA
    J Virol; 2015 May; 89(10):5651-67. PubMed ID: 25762737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.
    Sandbulte MR; Gauger PC; Kitikoon P; Chen H; Perez DR; Roth JA; Vincent AL
    Vaccine; 2016 Jul; 34(33):3773-9. PubMed ID: 27325350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.